# CRISPR Therapeutics AG: Form 8-K, filed Jun 4, 2026

- Company: [CRISPR Therapeutics AG](/companies/crsp.md) (CIK 1674416)
- Form: 8-K
- Filed: 2026-06-04
- Accepted by EDGAR: Jun 4, 2026, 16:45 ET
- Period: 2026-06-04
- Accession: 0001193125-26-257593
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674416/000119312526257593/crsp-20260604.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674416/000119312526257593/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674416/000119312526257593/crsp-20260604.htm

Filed Jun 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-257593. Last ingested by Listed: Oct 29, 2026, 04:32 ET. No prices; not investment advice.